The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Intravesical local administration of pembrolizumab for treatment of bladder cancer: A novel strategy to minimize toxicity.
 
Pradeep Tyagi
Consulting or Advisory Role - Lipella Pharmaceuticals
 
Anirban B. Ganguly
No Relationships to Disclose
 
Jason Hafron
Employment - Michigan Institute of Urology
Honoraria - Amgen; Astellas Pharma; Bayer; Blue Earth Diagnostics; Dendreon; Janssen Biotech; Lantheus Medical Imaging; Merck; Myovant Sciences; Myriad Genetics; Pfizer; Procept Biorobotics; Tolmar; Urogen pharma
Consulting or Advisory Role - Astellas Pharma; Dendreon; Janssen Biotech; Lilly; LynxDx; Myovant Sciences; Myriad Genetics; Pfizer; Promaxo
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Blue Earth Diagnostics; Dendreon; Janssen Biotech; Myovant Sciences; Myriad Genetics; Pfizer; Procept Biorobotics; Tolmar; Urogen pharma
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Dendreon (Inst); Janssen Biotech (Inst); Lipella Pharmaceuticals (Inst); Merck (Inst); miR Scientific (Inst); Myovant Sciences (Inst); Myriad Genetics (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Dendreon; Janssen Biotech; Merck; Myovant Sciences; Pfizer; Tolmar; Urogen pharma
 
Jonathan Kaufman
Employment - Lipella Pharmaceuticals
Leadership - Lipella Pharmaceuticals
Stock and Other Ownership Interests - Lipella Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Lipella Pharmaceuticals
 
Michael Chancellor
Employment - Lipella Pharmaceuticals
Leadership - Lipella Pharmaceuticals
Stock and Other Ownership Interests - Lipella Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Lipella Pharmaceuticals